Hence, many interventions aimed at controlling hyperglycemia in DM patients have been developed, including insulin injection for type 1 diabetes mellitus (T1DM) and non-insulin medications for type 2 diabetes mellitus (T2DM) via reversing the pathophysiological abnormalities that contribute to hyperglycemia [2]. This evidence concerns the gene INS and diabetes mellitus.